NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to NeuroPace’s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Neuropace Inc (NPCE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 3,406,335 | $38,116,889 | 0.78% | |
| 2. | Soleus Capital Guy Levy | 2,433,168 | $27,227,150 | 1.71% | |
| 3. | Kent Lake Capital Benjamin Natter | 1,482,555 | $16,589,790 | 7.01% | |
| 4. | Millennium Management Israel Englander | 643,211 | $7,197,531 | -14% | 0% |
| 5. | Armistice Capital Steven Boyd | 592,614 | $6,631,351 | +24% | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 62,398 | Large Shareholder | 4,432,948 | 2022-11-22 | Filing | |
| $1.50 | 327,893 | Large Shareholder | 4,370,550 | 2022-11-21 | Filing | |
| $17.00 | 235,000 | Large Shareholder | 235,000 | 2021-04-21 | Filing | |
| $17.00 | 2,352 | Officer | 2,352 | 2021-04-21 | Filing | |
| $17.00 | 588,235 | Large Shareholder | 588,235 | 2021-04-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.40 | 5,270,845 | Large Shareholder | 0 | 2025-02-20 | Filing | |
| $15.00 | 200 | 86,762 | 2025-01-30 | Filing | ||
| $15.00 | 100 | 86,962 | 2025-01-29 | Filing | ||
| $15.01 | 3,200 | 87,062 | 2025-01-24 | Filing | ||
| $5.45 | 223,991 | Large Shareholder | 5,270,845 | 2024-10-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,270,845 | $58,980,756 | 78.68% | |
| 2. | 2,491,830 | $27,883,578 | 0% | |
| 3. | 1,057,295 | $11,831,130 | 0% | |
| 4. | 746,128 | $8,349,171 | 0% | |
| 5. | 412,612 | $4,617,129 | 0% |
News See All
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's Second Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's First Quarter 2024 Conference Call. As a reminder, this call is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript
NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.33.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the NeuroPace, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
20 Countries With Highest Rate of Epilepsy
In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to NeuroPace's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
